Phosphorylated Tau 181

This is a single-marker test measuring the concentration of p-Tau181 protein in the blood or cerebrospinal fluid. Elevated levels of p-Tau181 are associated with tauopathies, including Alzheimer's disease, and can be used to differentiate Alzheimer's from other neurodegenerative conditions. This biomarker is particularly valuable for early diagnosis, monitoring disease progression, and evaluating response to therapeutic interventions in Alzheimer's disease and related disorders.

This is a single-marker test measuring the concentration of p-Tau181 protein in the blood or cerebrospinal fluid. Elevated levels of p-Tau181 are associated with tauopathies, including Alzheimer's disease, and can be used to differentiate Alzheimer's from other neurodegenerative conditions. This biomarker is particularly valuable for early diagnosis, monitoring disease progression, and evaluating response to therapeutic interventions in Alzheimer's disease and related disorders.

Quest AD-Detect® Phosphorylated tau181(p-tau181), Plasma - p-tau181 is a diagnostic biomarker for Alzheimer's Disease (AD) that is useful in identifying patients with underlying AD tau pathology. It can predict the cognitive decline in AD/MCI patients and correlates with amyloid and tau PET results.